Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 8/20 | 0.71 |
| ▸ | LMNA | P02545 | 8/20 | 0.71 |
| ▸ | TSHR | P16473 | 5/20 | 0.71 |
| ▸ | MAPT | P10636 | 5/20 | 0.71 |
| ▸ | NR3C1 | P04150 | 4/20 | 0.71 |
| ▸ | PGR | P06401 | 4/20 | 0.71 |
| ▸ | AR | P10275 | 4/20 | 0.71 |
| ▸ | NR1I2 | O75469 | 3/20 | 0.71 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.71 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.71 |
| ▸ | CYP17A1 | P05093 | 2/20 | 0.71 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.71 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.69 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.61 |
| ▸ | SHBG | P04278 | 4/20 | 0.61 |
| ▸ | SERPINA6 | P08185 | 4/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.61 |
| ▸ | GPBAR1 | Q8TDU6 | 3/20 | 0.61 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.61 |
| ▸ | SNCA | P37840 | 2/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4264019 | 1.00 | CYP3A4 (0.71) | CYP3A4LMNATSHRMAPTNR3C1 | |
| SCHEMBL6897111 | 0.91 | CYP3A4 (0.69) | CYP3A4LMNATSHRMAPTNR3C1 | |
| SCHEMBL6897116 | 0.91 | CYP3A4 (0.69) | CYP3A4LMNATSHRMAPTNR3C1 | |
| SCHEMBL6894352 | 0.90 | CYP3A4 (0.68) | CYP3A4LMNATSHRMAPTNR3C1 | |
| SCHEMBL6894357 | 0.90 | CYP3A4 (0.68) | CYP3A4LMNATSHRMAPTNR3C1 | |
| SCHEMBL6902306 | 0.90 | CYP3A4 (0.68) | CYP3A4LMNATSHRMAPTNR3C1 | |
| SCHEMBL6901280 | 0.90 | CYP3A4 (0.68) | CYP3A4LMNATSHRMAPTNR3C1 | |
| SCHEMBL6901756 | 0.90 | CYP3A4 (0.68) | CYP3A4LMNATSHRMAPTNR3C1 | |
| SCHEMBL6901750 | 0.90 | CYP3A4 (0.68) | CYP3A4LMNATSHRMAPTNR3C1 | |
| SCHEMBL6902307 | 0.90 | CYP3A4 (0.68) | CYP3A4LMNATSHRMAPTNR3C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115128178-B | Full-automatic detection method for various steroid esters in dried blood spot sample | 上海体育大学 | 2023-08-25 | — | — | CN | claimed |
| CN-115521920-B | Testosterone propionate monoclonal antibody hybridoma cell strain and application thereof | 江南大学 | 2023-06-06 | — | — | CN | claimed |
| CN-113134085-A | Medicine for treating white lesions of vulva | 四川大学华西第二医院 | 2021-07-20 | — | — | CN | claimed |
| US-20260014080-A1 | LIPOSOMAL PREPARATION WITH ENCAPSULATED HORMONES, METHOD OF PRODUCTION AND USE THEREOF | VAN BOGAERT GINA (BE) | 2026-01-15 | — | — | US | disclosed |
| US-20250281509-A1 | SEQUENTIAL HORMONE THERAPY TO IMPROVE SURVIVAL AND ENHANCE RESPONSE TO IMMUNE THERAPY IN MEN WITH PROSTATE CANCER | THE JOHNS HOPKINS UNIVERSTY | 2025-09-11 | — | — | US | disclosed |
| CN-118150725-A | Full-automatic pretreatment system, full-automatic detection method and application of dried blood spot sample | 上海体育大学 | 2024-06-07 | — | — | CN | disclosed |
| WO-2023223235-A1 | LIPOSOMAL PREPARATION WITH ENCAPSULATED HORMONES, METHOD OF PRODUCTION AND USE THEREOF | PURNA PHARMACEUTICALS NV (BE) | 2023-11-23 | — | — | WO | disclosed |
| CN-113134085-A | Medicine for treating white lesions of vulva | 四川大学华西第二医院 | 2021-07-20 | — | — | CN | disclosed |
| US-20160209428-A1 | DIAGNOSTIC AND PREDICTIVE METABOLITE PATTERNS FOR DISORDERS AFFECTING THE BRAIN AND NERVOUS SYSTEM | The United States of America as represented by the Department of Veterans Affairs, Office of the General Counsel | 2016-07-21 | — | — | US | disclosed |
| WO-2015027116-A1 | DIAGNOSTIC AND PREDICTIVE METABOLITE PATTERNS FOR DISORDERS AFFECTING THE BRAIN AND NERVOUS SYSTEM | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-02-26 | — | — | WO | disclosed |
| CN-101460846-A | Method for detecting modulators of membrane androgen receptor (mAR) | MEDEXIS S A (GR) | 2009-06-17 | — | — | CN | disclosed |
| US-20090104122-A1 | DETECTION OF MEMBRANE ANDROGEN RECEPTOR (mAR) AGENTS | MEDEXIS S.A. (GR) | 2009-04-23 | — | — | US | disclosed |
| EP-2008099-A2 | DETECTION OF MEMBRANE ANDROGEN RECEPTOR (MAR) AGENTS | Medexis S.A. (GR) | 2008-12-31 | — | — | EP | disclosed |
| WO-2007123682-A2 | DETECTION OF MEMBRANE ANDROGEN RECEPTOR (MAR) AGENTS | MEDEXIS S.A. (GR) | 2007-11-01 | — | — | WO | disclosed |
| US-20060292185-A1 | Topical skin preparations for treatment of skin aging comprising a testosterone ester | TOPIMED LTD. (IL) | 2006-12-28 | — | — | US | disclosed |
| US-6274118-B1 | INJECTING PATIENT HAVING ENDOCRINE CANCER IN NON-PROSTATIC TISSUE WITH BIOLOGICAL BINDING UNITS WHICH BIND TO PROSTATE SPECIFIC ANTIGEN PRODUCED BY NON-PROSTATIC TISSUE | NORDION INTERNATIONAL INC. (CA) | 2001-08-14 | — | — | US | disclosed |
| US-4219489-A | Synthesis of steroids | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 1980-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260014080-A1 | LIPOSOMAL PREPARATION WITH ENCAPSULATED HORMONES, METHOD OF PRODUCTION AND USE THEREOF | NR5A1, SHBG, GNRHR | CYP3A4 1458/4885LMNA 796/4885TSHR 232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.